Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational ...

The global cell-free protein expression market size was US$ 225.09 million in 2021. The global cell-free protein expression market is expected to grow to US$ 451.1 million by 2030 by registering a ...

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...

Cancer dysregulates the complex structure of tissues and internal cellular pathways. As a result, the immune system loses its ...

As drug developers face mounting pressure to accelerate discovery timelines without sacrificing quality, QLNS-CHO offers a compelling solution.

Novel genetic insights into frailty highlight potential early predictors, aiding in the prevention of age-related decline and ...

Protein has become an inescapably present nutrient. It makes expected appearances, as in the peak hype-cycle David’s protein ...

Many major cancers, including those of the lung, breast and prostate gland, spread to the bones as they progress. These bone ...

The emerging role of SETD2 in regulating immune cell function is shedding light on potential therapeutic strategies for a ...

Currently, GenAns Biotech is conducting investigator-initiated trials for several gene therapies, including GA001 for ...

WACKER and Gearbox Biosciences have launched a partnership to co-develop advanced, antibiotic-free pDNA manufacturing techniques aimed at improvi ...